These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 898908)

  • 41. [Clinical experiences with the serum digitalis concentration. 1006 radioimmunological determinations].
    Moccetti T; Ferrini B; Salvadè G; Rakusa M; Bogenmann F; Riva A; Clara F
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1822-5. PubMed ID: 929143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical symptoms, electrocardiographic signs and blood digitalis in a group of patients with digitalis poisoning].
    Bernabei R; Leporelli M; Di Nardo P; Carosella L; Carbonin PU
    Boll Soc Ital Cardiol; 1978; 23(10):1617-22. PubMed ID: 261828
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of the digoxin concentration in the blood plasma of patients with cardiopulmonary failure].
    Sidorova LD; Arkhipova GF; Kudelia LM; Pavlova IP
    Farmakol Toksikol; 1986; 49(5):22-5. PubMed ID: 3770167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of a double blind study with Segontin-Digoxin in coronary heart disease (author's transl)].
    Nossen J
    MMW Munch Med Wochenschr; 1977 Feb; 119(5):159-62. PubMed ID: 402569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On digitalis therapy, especially on trials of the digoxin preparations Digacin and T-A-Digacin].
    Müller H; Müller L
    Hippokrates; 1965 Jul; 36(14):547-55. PubMed ID: 5319184
    [No Abstract]   [Full Text] [Related]  

  • 46. Preparation of a patient with cardiovascular disease for surgery.
    Friedlander DH
    N Z Med J; 1973 Nov; 78(503):444-8. PubMed ID: 4149713
    [No Abstract]   [Full Text] [Related]  

  • 47. [Role of digitalis in the pharmacologic treatment of cardiac insufficiency].
    Ramalhão C
    Rev Port Cardiol; 1989 Jun; 8(6):469. PubMed ID: 2631852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Digoxin therapy in patients with long-term digitalis therapy. Comparison of the digoxin blood level after oral administration of digoxin and beta-methyldigoxin].
    Hennersdorf G; Leithäuser H
    Fortschr Med; 1980 Mar; 98(11):(410-2). PubMed ID: 7372228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Variability of the therapeutic response to digitalis. Relation between administered dose, serum level and myocardial concentration of the drug].
    Carbonin PU
    G Ital Cardiol; 1978; 8(4):355-8. PubMed ID: 648779
    [No Abstract]   [Full Text] [Related]  

  • 50. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 52. [Study of the bioavailability of some digitalis preparations].
    Gavrilescu S; Cristodorescu R; Deutsch G; Puşchiţa M; Popoviciu V; Mihalaş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(3):233-42. PubMed ID: 41306
    [No Abstract]   [Full Text] [Related]  

  • 53. [Digoxin treatment procedures and some ways to avoid glycoside poisoning].
    Kamenker SM
    Klin Med (Mosk); 1978 Oct; 56(10):68-74. PubMed ID: 713462
    [No Abstract]   [Full Text] [Related]  

  • 54. [Underdosing and overdosing with digitalis].
    Hess T
    Schweiz Med Wochenschr; 1981 Mar; 111(13):455-60. PubMed ID: 7233124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do digitalis glycosides still have a role in congestive heart failure?
    Young JB
    Cardiol Clin; 1994 Feb; 12(1):51-61. PubMed ID: 8181025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Limited indications for glycoside therapy in pediatrics?].
    Döhlemann C; Güntner M; Vogel M
    Fortschr Med; 1984 Oct; 102(40):1009-12. PubMed ID: 6500460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of heart insufficiency by monitoring with microcatheterization of the right heart].
    Wallnöfer H; Täuber K; Jetschgo G
    Wien Med Wochenschr; 1971 Sep; 121(39):679-85. PubMed ID: 5110496
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical studies of beta-methyl-digoxin in patients with cardiac decompensation].
    Raĭcheva L; Popov NG; Vasilev T; Lazarov G
    Vutr Boles; 1975; 14(5):49-56. PubMed ID: 772974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)].
    Fan-Tkhi-Ngok-Shiong
    Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effectiveness of beta-methyldigoxin in latent cardiac insufficiency: cardiodynamic study].
    Candotti C; Piscitello F; Mezzadri M
    Clin Ter; 1980 Sep; 94(6):671-8. PubMed ID: 7460501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.